{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:15:51Z","timestamp":1773796551677,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00520-022-07002-9","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T22:03:37Z","timestamp":1648677817000},"page":"5831-5836","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Risk factors for opioid-induced constipation in cancer patients: a single-institution, retrospective analysis"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0095-2293","authenticated-orcid":false,"given":"Yuko","family":"Kanbayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Ishizuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsushige","family":"Yabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayako","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,31]]},"reference":[{"key":"7002_CR1","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1007\/s00520-011-1281-y","volume":"19","author":"S Mercadante","year":"2011","unstructured":"Mercadante S (2011) Emerging drugs for cancer-related pain. Support Care Cancer 19:1887\u20131893","journal-title":"Support Care Cancer"},{"key":"7002_CR2","first-page":"CD012592","volume":"7","author":"PJ Wiffen","year":"2017","unstructured":"Wiffen PJ, Wee B, Derry S, Bell RF, Moore RA (2017) Opioids for cancer pain - an overview of Cochrane reviews. Cochrane Database Syst Rev 7:CD012592","journal-title":"Cochrane Database Syst Rev"},{"key":"7002_CR3","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1517\/14740338.2015.1041915","volume":"14","author":"D Krashin","year":"2015","unstructured":"Krashin D, Murinova N, Jumelle P, Ballantyne J (2015) Opioid risk assessment in palliative medicine. Expert Opin Drug Saf 14:1023\u20131033","journal-title":"Expert Opin Drug Saf"},{"key":"7002_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12904-020-00693-z","volume":"20","author":"RG Sarri\u00f3","year":"2021","unstructured":"Sarri\u00f3 RG, Calsina-Berna A, Garc\u00eda AG, Esparza-Mi\u00f1ana JM, Ferrer EF, Working Group ActEIO Project, Porta-Sales J (2021) Delphi consensus on strategies in the management of opioid-induced constipation in cancer patients. BMC Palliat Care 20:1","journal-title":"BMC Palliat Care"},{"key":"7002_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11864-019-0686-6","volume":"20","author":"R Mes\u00eda","year":"2019","unstructured":"Mes\u00eda R, Virizuela Echaburu JA, G\u00f3mez J, Sauri T, Serrano G, Pujol E (2019) Opioid-induced constipation in oncological patients: new strategies of management. Curr Treat Options Oncol 20:91","journal-title":"Curr Treat Options Oncol"},{"key":"7002_CR6","first-page":"e14386","volume":"13","author":"N ALMouaalamy","year":"2021","unstructured":"ALMouaalamy N (2021) Opioid-induced constipation in advanced cancer patients. Cureus 13:e14386","journal-title":"Cureus"},{"key":"7002_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s10147-020-01790-y","volume":"26","author":"T Harada","year":"2021","unstructured":"Harada T, Imai H, Fumita S, Noriyuki T, Gamoh M, Okamoto M, Akashi Y, Kizawa Y, Tokoro A (2021) Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with gastrointestinal cancer. Int J Clin Oncol 26:104\u2013110","journal-title":"Int J Clin Oncol"},{"key":"7002_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/23809000.2016.1131595","volume":"1","author":"A Rumman","year":"2016","unstructured":"Rumman A, Gallinger ZR, Liu LWC (2016) Opioid induced constipation in cancer patients: pathophysiology, diagnosis and treatment. Expert Rev Qual Life Cancer Care 1:25\u201335","journal-title":"Expert Rev Qual Life Cancer Care"},{"key":"7002_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/2050640618818305","volume":"7","author":"AD Farmer","year":"2019","unstructured":"Farmer AD, Drewes AM, Chiarioni G, De Giorgio R, O\u2019Brien T, Morlion B, Tack J (2019) Pathophysiology and management of opioid-induced constipation: European expert consensus statement. United European Gastroenterol J 7:7\u201320","journal-title":"United European Gastroenterol J"},{"key":"7002_CR10","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1097\/AJP.0000000000000852","volume":"36","author":"CE Argoff","year":"2020","unstructured":"Argoff CE (2020) Opioid-induced constipation: a review of health-related quality of life, patient burden, practical clinical considerations, and the impact of peripherally acting \u03bc-opioid receptor antagonists. Clin J Pain 36:716\u2013722","journal-title":"Clin J Pain"},{"key":"7002_CR11","doi-asserted-by":"crossref","unstructured":"Larkin PJ, Cherny NI, La Carpia D, Guglielmo M, Ostgathe C, Scott\u00e9 F, Ripamonti CI; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org (2018) Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines. Ann Oncol 29 Suppl 4:iv111-iv125","DOI":"10.1093\/annonc\/mdy148"},{"key":"7002_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00520-019-05016-4","volume":"28","author":"A Davies","year":"2020","unstructured":"Davies A, Leach C, Caponero R, Dickman A, Fuchs D, Paice J, Emmanuel A (2020) MASCC recommendations on the management of constipation in patients with advanced cancer. Support Care Cancer 28:23\u201333","journal-title":"Support Care Cancer"},{"issue":"16","key":"7002_CR13","first-page":"00222","volume":"S0016\u20135085","author":"F Mearin","year":"2016","unstructured":"Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, Spiller R (2016) Bowel disorders. Gastroenterology S0016\u20135085(16):00222\u201300225","journal-title":"Gastroenterology"},{"issue":"16","key":"7002_CR14","first-page":"00180","volume":"S0016\u20135085","author":"OS Palsson","year":"2016","unstructured":"Palsson OS, Whitehead WE, van Tilburg MA, Chang L, Chey W, Crowell MD, Keefer L, Lembo AJ, Parkman HP, Rao SS, Sperber A, Spiegel B, Tack J, Vanner S, Walker LS, Whorwell P, Yang Y (2016) Rome IV diagnostic questionnaires and tables for investigators and clinicians. Gastroenterology S0016\u20135085(16):00180\u201300183","journal-title":"Gastroenterology"},{"key":"7002_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11894-017-0554-0","volume":"19","author":"M Simren","year":"2017","unstructured":"Simren M, Palsson OS, Whitehead WE (2017) Update on Rome IV criteria for colorectal disorders: implications for clinical practice. Curr Gastroenterol Rep 19:15","journal-title":"Curr Gastroenterol Rep"},{"key":"7002_CR16","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1053\/j.gastro.2019.12.021","volume":"158","author":"OS Palsson","year":"2020","unstructured":"Palsson OS, Whitehead W, T\u00f6rnblom H, Sperber AD, Simren M (2020) Prevalence of Rome IV functional bowel disorders among adults in the United States, Canada, and the United Kingdom. Gastroenterology 158:1262-1273.e3","journal-title":"Gastroenterology"},{"key":"7002_CR17","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1080\/07315724.2020.1727380","volume":"39","author":"G Yurtda\u015f","year":"2020","unstructured":"Yurtda\u015f G, Acar-Tek N, Akbulut G, Cemali \u00d6, Arslan N, Beyaz Co\u015fkun A, Zengin FH (2020) Risk factors for constipation in adults: a cross-sectional study. J Am Coll Nutr 39:713\u2013719","journal-title":"J Am Coll Nutr"},{"key":"7002_CR18","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1007\/s00192-021-04723-z","volume":"32","author":"L Cattani","year":"2021","unstructured":"Cattani L, Neefs L, Verbakel JY, Bosteels J, Deprest J (2021) Obstetric risk factors for anorectal dysfunction after delivery: a systematic review and meta-analysis. Int Urogynecol J 32:2325\u20132336","journal-title":"Int Urogynecol J"},{"key":"7002_CR19","unstructured":"World Health Organization. Body mass index\u2014BMI. 2021. (https:\/\/www.euro.who.int\/en\/health-topics\/disease-prevention\/nutrition\/a-healthy-lifestyle\/body-mass-index-bmi). Accessed October 17, (2021)"},{"key":"7002_CR20","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1634\/theoncologist.2018-0590","volume":"24","author":"KA Nyrop","year":"2019","unstructured":"Nyrop KA, Deal AM, Shachar SS, Basch E, Reeve BB, Choi SK, Lee JT, Wood WA, Anders CK, Carey LA, Dees EC, Jolly TA, Reeder-Hayes KE, Kimmick GG, Karuturi MS, Reinbolt RE, Speca JC, Muss HB (2019) Patient-reported toxicities during chemotherapy regimens in current clinical practice for early breast cancer. Oncologist 24:762\u2013771","journal-title":"Oncologist"},{"key":"7002_CR21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1053\/j.gastro.2018.10.044","volume":"156","author":"S Crockett","year":"2019","unstructured":"Crockett S, Greer KB, Sultan S (2019) Opioid-induced constipation (OIC) guideline. Gastroenterology 156:228","journal-title":"Gastroenterology"},{"key":"7002_CR22","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.amjmed.2018.02.038","volume":"131","author":"JM Garcia","year":"2018","unstructured":"Garcia JM, Shamliyan TA (2018) Management of opioid-induced constipation in patients with malignancy. Am J Med 131:1041-1051.e3","journal-title":"Am J Med"},{"key":"7002_CR23","first-page":"1837","volume":"18","author":"S M\u00fcller-Lissner","year":"2017","unstructured":"M\u00fcller-Lissner S, Bassotti G, Coffin B, Drewes AM, Breivik H, Eisenberg E, Emmanuel A, Laroche F, Meissner W, Morlion B (2017) Opioid-induced constipation and bowel dysfunction: a clinical guideline. Pain Med 18:1837\u20131863","journal-title":"Pain Med"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-07002-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-022-07002-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-07002-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T05:26:41Z","timestamp":1653542801000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-022-07002-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,31]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["7002"],"URL":"https:\/\/doi.org\/10.1007\/s00520-022-07002-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1036462\/v1","asserted-by":"object"}]},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,31]]},"assertion":[{"value":"31 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Medical Ethics Review Committee of Seirei Hamamatsu General Hospital approval no. 3310 and the Faculty of Pharmacy, Osaka Medical Pharmaceutical University, approved this study, approval no. 0088. All procedures were performed in accordance with the ethical standards of the Seirei Hamamatsu General Hospital and Osaka Medical Pharmaceutical University of Medicine Institutional Medical Ethics Review Committee and the 1964 Declaration of Helsinki and its later amendments. No prospective studies with human participants or animals were performed by any of the authors for this article.This study retrospectively analyzed 208 cancer patients newly prescribed laxatives for OIC or OIC prevention at Seirei Hamamatsu General Hospital between November 2016 and June 2021. All study protocols were approved by the Medical Ethics Review Committee at Seirei Hamamatsu General Hospital (approval no. 3310) and the Faculty of Pharmacy at Osaka Medical Pharmaceutical University (approval no. 0088).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Given the retrospective nature of this work, the need to obtain informed consent was waived for the individual participants included in the study, in accordance with the standards of the Seirei Hamamatsu General Hospital and Osaka Medical Pharmaceutical University of Medicine Institutional Medical Ethics Review Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors give their consent for this manuscript to be published in <i>Supportive Care in Cancer.<\/i>","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}